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Dysregulation of Striatal Dopamine Signaling
by Amphetamine Inhibits Feeding by Hungry Mice
AMPH on human appetite and body weight, the mecha-
nisms of AMPH-induced hypophagia and weight loss
have been investigated extensively.
Claire Matson Cannon,1,* Luna Abdallah,2
Laurence H. Tecott,2 Matthew J. During,3
and Richard D. Palmiter1
1Department of Biochemistry and A substantial literature is consistent with the hypothe-
sis that systemic AMPH reduces appetite by release ofHoward Hughes Medical Institute
University of Washington catecholamines within the perifornical lateral hypothala-
mus (pfLH) (Baptista et al., 1993; Chen et al., 2001; Kuo,Seattle, Washington 98195
2 Department of Psychiatry and 2003; Leibowitz, 1975a, 1975b; Leibowitz and Shor-
Posner, 1986; Wellman, 1990). In support of this hypoth-Center for Neurobiology and Psychiatry
University of California, San Francisco esis, AMPH, DA, NE, and Epi, as well as pharmacological
agonists of dopamine D2 and -adrenergic receptors,San Francisco, California 94143
3 Department of Molecular Medicine and Pathology reduce food intake when injected locally into the pfLH
(Booth, 1968; Leibowitz and Rossakis, 1979), and localUniversity of Auckland
Auckland D2 and -adrenergic antagonists can stimulate feeding
in sated animals (Leibowitz, 1970b; Parada et al., 1988b).New Zealand
Finally, pfLH D2 and -adrenergic antagonists attenuate
the hypophagic effect of locally injected AMPH (Leibo-
witz, 1975a).Summary
Here, we sought to investigate the mechanism of
AMPH-induced hypophagia by using a genetic ap-Amphetamine (AMPH) releases monoamines, tran-
siently stimulates locomotion, and inhibits feeding. proach. We tested whether AMPH-induced hypophagia
requires activation of DA and -adrenergic receptorsUsing a genetic approach, we show that mice lacking
dopamine (DA-deficient, or DD, mice) are resistant to (Leibowitz, 1975a, 1975b) by using mice that lack the
endogenous -adrenergic ligands NE and Epi (Dbh/),the hypophagic effects of a moderate dose of AMPH
(2g/g) but manifest normal AMPH-induced hypopha- dopamine D2 receptors (D2r/), or dopamine D1 recep-
tors (D1r/). We also tested three mouse models withgia after restoration of DA signaling in the caudate
putamen by viral gene therapy. By contrast, AMPH- genetic modification of hypothalamic feeding effectors:
neuropeptide Y (Npy/) and serotonin 2C receptorinduced hypophagia in response to the same dose of
AMPH is not blunted in mice lacking the ability to make (Htr2c/Y) knockout and agouti (Ay) mice. Finally, we
tested mice that lack the ability to make DA (DA-defi-norepinephrine and epinephrine (Dbh/), dopamine D2
receptors (D2r/), dopamine D1 receptors (D1r/), cient, or DD, mice), before and after restoration of DA
signaling to the caudate-putamen (CPu) by virally medi-serotonin 2C receptors (Htr2c/Y), neuropeptide Y
(Npy/), and in mice with compromised melanocortin ated gene transfer. The results of these experiments,
along with a review of the literature, lead us to a newsignaling (Ay). We suggest that, at this moderate dose
of AMPH, dysregulation of striatal DA is the primary hypothesis to account for the hypophagia induced by
a moderate dose of AMPH and the role of striatal DA incause of AMPH-induced hypophagia and that regu-
lated striatal dopaminergic signaling may be neces- feeding behavior.
sary for normal feeding behaviors.
Results and Discussion
Introduction
The general strategy used in most of the studies re-
Amphetamine (AMPH) was widely prescribed for the ported here to assess the effects of AMPH on food
treatment of obesity between 1937 and 1970 and has intake and locomotion is depicted in Figure 1A. For these
served as a prototype for the development of subse- studies, we chose to use a moderate dose of AMPH
quent anorexic drugs, such as phentermine. Acute, sys- (2g/g) that results in a substantial, though not absolute,
temic AMPH releases the biogenic amines dopamine reduction in food intake during the first hour after treat-
(DA), norepinephrine (NE), epinephrine (Epi), and seroto- ment (Figure 1B) as well as significant locomotor activa-
nin (5-HT), flooding the synaptic cleft with excess ligand tion (Figure 1C).
(Sulzer et al., 1995). In addition to reducing food intake,
AMPH increases blood pressure, locomotor activity, ox- NE, Epi, D2, and D1 Receptors Are Not Required
ygen consumption, and heart and respiratory rates and for AMPH-Induced Hypophagia
can result in dry mouth, sweating, enlargement of the Because both -adrenergic and dopamine D2 receptor
pupils, and slowed gastrointestinal transit time. Humans antagonists infused directly into the pfLH were able to
treated with AMPH report euphoria, increased attention, attenuate the hypophagia caused by a low dose of
feelings of confidence, restlessness, difficulty sleeping, AMPH, it has been suggested that the function of either
and headaches, while some may become anxious, irrita- of these receptors is required for the suppressive effects
ble, hostile, and aggressive. Because of the effects of of AMPH on eating (Leibowitz, 1975a). To test the impor-
tance of-adrenergic signaling, we examined mice lack-
ing dopamine -hydroxylase (Dbh/), which is essential*Correspondence: caesia@u.washington.edu
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Figure 1. Procedure for Tests of AMPH-
Induced Hypophagia
(A) Food was removed and mice were trans-
ferred to a new home cage 24 hr prior to the
beginning of each test. Because of hyperpha-
gia in response to fresh chow pellets, pellets
from each cage were bagged separately and
returned to the same mice for testing. After
22 hr of fasting, mice were transferred to the
activity chamber to acclimate. Activity data
were collected as ambulations (consecutive
breaks to two separate beams) per 15 min
interval. Two hours later, mice were weighed,
injected with PBS or AMPH and returned to
the activity chamber. Mice were always ob-
served during the first 30 min after AMPH
administration and were usually observed at
intervals throughout the test. Weighed food
was returned immediately after injection, then
removed, weighed, and returned at 0.5, 1, and
2 hr. The calculated difference in weight was
assumed to represent food intake by the
mouse. Water was available at all times. After 2 hr, mice were returned to the home cage where food was available ad libitum. Tests were
separated by a minimum of 2 days. On the first 2 testing days, mice were acclimated to the procedure and given only PBS. AMPH or PBS
was given in counterbalanced order on the last 2 testing days.
(B) Because mice sensitize to repeated treatment with AMPH, separate groups of C57BL/6J mice were used for each dose of AMPH. Data
for each mouse were converted to a percentage of the fasting-induced intake of the same mouse following PBS injection. Doses of 1 (n 
8), 2 (n  12), or 5 (n  16) g/g AMPH reduced fasting-induced feeding in the first 30–60 min after treatment, with the effect of 5 g/g
persisting through the second hour. Lower doses of 0.8 (n  8, data not shown), 0.5 (n  7), and 0.2 (n  12, data not shown) g/g AMPH
resulted in some stimulation of feeding behavior, particularly late in the testing interval. In a separate study (data not shown), we observed
no difference between male and female mice in the hypophagic response to 2 or 5 g/g AMPH.
(C) As a percentage of the activity before and after PBS injection, both 2 and 5 g/g AMPH resulted in increased ambulations. Lower doses
did not reliably increase ambulations in all mice. For clarity, some of the lower doses are not shown. A separate study confirmed no difference
between the ambulatory response of male and female mice to AMPH in this protocol (data not shown).
for the synthesis of the -adrenergic ligands NE and that NE and Epi are not required for AMPH-induced
hypophagia even in the presence of DA receptorEpi. Female Dbh/ and Dbh/ mice reduced food intake
equally after AMPH (Figure 2A), as did male Dbh/ and blockade.
Mice lacking dopamine D2 receptors (D2r/) also re-Dbh/ mice (data not shown). Basal ambulations by
Dbh/ mice were slightly less than that of Dbh/ con- sponded to AMPH with hypophagia equivalent to that
of their littermate controls (D2r/). Female D2r/ andtrols, as was their ambulatory response to AMPH (Figure
2B). While the hypophagic response of Dbh/ mice to D2r/ mice reduced their food intake (Figures 3A and
3C) and increased their activity (Figures 3B and 3D) afterAMPH suggests that activation of -adrenergic recep-
tors is not required for AMPH-induced hypophagia, we AMPH, as do males (data not shown). The -adrenergic
receptor antagonist propranolol (PROP, 1.25 g/g) didsought to exclude the possibility that activation of D2
receptors compensated for the loss of NE and Epi in not block AMPH-induced hypophagia (Figure 3E) or hy-
peractivity (Figure 3F) in female D2r/ or D2r/ mice.these mice by blocking D2 receptors with haloperidol
(HAL). The dose of HAL (0.25 g/g) was chosen because This dose of PROP was chosen because it maintains
relative specificity and reversed restraint stress-inducedit did not cause catalepsy or increase feeding by mice
within the first 2 hr of administration, whereas higher behavior in mice (Gorman and Dunn, 1993). Even higher
doses of PROP (4–16 g/g) fail to block AMPH-induceddoses (0.5 and 1.0 g/g) did increase feeding (Kaur and
Kulkarni, 2002). Despite blocking striatal dopaminergic hypophagia in mice (Dobrzanski and Doggett, 1979) and
rats (Chen et al., 2001; Lazareno, 1979; Willner and Tow-activation after AMPH, as evidenced by the absence of
AMPH-induced hyperactivity (Figures 2D and 2F), HAL ell, 1982). We conclude that signaling via -adrenergic
receptors does not compensate for the lack of D2 recep-did not counter AMPH-induced hypophagia in Dbh/
or Dbh/ mice (Figures 2C and 2E), in contrast to the tor signaling during AMPH-induced hypophagia.
Although there are few D1 receptors present in the“behavioral competition” hypothesis (Blundell and Rog-
ers, 1980; Joyce and Iversen, 1984). A trend at 30 min pfLH and HAL is selective for D2-like receptors at low
doses, it is possible that the high dose of HAL givenafter injection (F[1,14] 1.7, p 0.22) toward increased
intake following HAL and AMPH in the Dbh/ mice as directly into the pfLH inhibited D1 receptors (Leibowitz,
1975b). This interpretation might explain why systemiccompared to the controls treated in the same way may
suggest enhanced sensitivity to the effects of HAL or administration of a selective D1-type receptor antagonist
(SCH23390) blocked hypophagia in response to a lowmerely the increased basal intake of the knockouts. In
a previous report (Leibowitz, 1975b), the large amount dose of AMPH, while the D2-type antagonist sulpiride
did not (Gilbert and Cooper, 1985; Lutz et al., 2001).of HAL injected into the pfLH (3.8 g/side) may have
had nonspecific effects; moreover, the effects of this Therefore, we also sought to evaluate AMPH-induced
hypophagia in mice lacking dopamine D1 receptorsdose of HAL alone were not reported. We conclude
Genetic Studies of Amphetamine-Induced Hypophagia
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Figure 3. D2r/ Mice Reduced Fasting-Induced Food Intake and
Increased Locomotion after AMPH, Regardless of -Adrenergic
Figure 2. Dbh/ and Dbh/ Mice Reduced Fasting-Induced Intake Blockade
after AMPH, but Did Not Increase Locomotion during D2 Receptor (A) Naive 2-month-old female mice (12 D2r/ and 12 D2r/) wereBlockade
significantly hypophagic in response to AMPH (2 g/g) as compared
(A) Naive 2-month-old female mice (8 Dbh/ and 8 Dbh/) demon- to deprivation-induced intake after PBS injection (p  0.01).
strated significant hypophagia in response to AMPH (2 g/g) as (B) The activity of female D2r/ mice after AMPH was comparable
compared to deprivation-induced intake after PBS injection (p  to that of the D2r/ controls, and neither group demonstrated ste-
0.01 by Tukey’s post hoc analysis). The Dbh/ mice consumed more reotypy.
food during the first 0.5 and 1 hr after PBS injection (values shown (C) Naive 4-month-old female mice (8 D2r/ and 7 D2r/) were
are the average of three PBS trials, p  0.01), which may reflect pretreated with PBS 15 min prior to either PBS or AMPH. Female
aberrant satiety mechanisms mice of both genotypes were significantly hypophagic in response
(B) Both Dbh/ controls and Dbh/ mice responded to AMPH with to AMPH (2 g/g) as compared to deprivation-induced intake after
hyperactivity, and neither group demonstrated stereotypy. The ac- PBS injection (p  0.01).
tivity of Dbh/ mice was slightly less than that of the controls, (D) Both D2r/ and D2r/ mice became hyperactive in response
F(1,14)  5, p  0.05. to AMPH.
(C) After a break of 2 months, the same mice were tested again to (E) Propranolol (PROP; 1.25 g/g) did not significantly affect AMPH-
determine the effect of the D2 receptor antagonist HAL on AMPH- induced hypophagia in D2r/ controls or D2r/ mice (p  0.91).
induced hypophagia and locomotion. When PBS was given 15 min (F) There was no effect of prior PROP on activity after AMPH, and
prior to PBS or AMPH, female mice of both genotypes were signifi- neither group demonstrated stereotypy.
cantly hypophagic in response to AMPH (2 g/g) as compared to
deprivation-induced intake after PBS injection (p  0.01).
(D) AMPH induced hyperlocomotion, and neither group demon- (D1r/ mice). D1r/ mice reduced food intake after
strated stereotypy.
AMPH (Figure 4A) and became hyperactive (Figure 4B).(E) All mice received the DA receptor antagonist haloperidol (HAL;
Although there was a trend toward reduced ambulations0.25 g/g IP) 15 min prior to injection of PBS or AMPH and return
after AMPH by the D1r/ mice, this did not reach signifi-of food. HAL did not affect hyperphagia following a fast or AMPH-
induced hypophagia in Dbh/ controls or Dbh/ mice (p  0.87). cance. However, the trend toward increased basal activ-
(F) Prior treatment with HAL completely counteracted the locomotor ity in the fasted D1r/ mice was significant (p  0.05).
effect of AMPH in both Dbh/ controls and Dbh/ mice (p  0.01). We were unable to test mice lacking both D1 and D2
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as hyperphagic after a fast as were the lean (20.5  0.6)
controls (Figure 5C).
The release of NPY and AgRP by arcuate neurons is
thought to stimulate feeding. DA exerts tonic inhibitory
control over NPY expression in the arcuate nucleus (Li
and Pelletier, 1986; Obuchowicz, 1996; Pelletier and Si-
mard, 1991), and it has been hypothesized that NPY
participates in the hypophagic response to AMPH (Gil-
lard et al., 1993; Kuo, 2003; Kuo et al., 2001). At a dose
of 2 g/g AMPH, Npy/ and Npy/ mice displayed
equivalent AMPH-induced hypophagia and hyperactiv-
ity (Figures 5E and 5F). However, the locomotor re-
sponse of these mice, maintained on the 129/SvCPJ
background, was markedly less than that of mice main-
tained on the C57BL/6 strain. Therefore, an additional
Figure 4. D1r/ Mice Reduced Fasting-Induced Food Intake and experiment was conducted with a higher (4 g/g) dose
Increased Locomotion after AMPH
of AMPH. We again observed no difference between the
(A) Naive 4-month-old male and female mice (7 D1r/ and 6 D1r/)
Npy/ and Npy/ mice in their hypophagic response towere significantly hypophagic in response to AMPH (2 g/g) as
AMPH. While a small trend appeared during the secondcompared to deprivation-induced intake after PBS injection (p 
hour, there was no difference between the intake of the0.01).
(B) The activity of the fasted D1r/ mice during the baseline period knockouts and that of the controls during the last hour
was significantly greater than that of the controls (p  0.05). After of the testing interval (p  0.99, Figure 5G). In contrast,
AMPH, both groups demonstrated comparable hyperactivity (p  Npy/ mice were more sensitive to the locomotor ef-
0.01).
fects of AMPH and quickly entered stereotypy (Figure
5H and the Supplemental Data [http://www.neuron.org/
cgi/content/full/44/3/509/DC1/]).
receptors, as these mice die perinatally (Kobayashi et Mice lacking serotonin 2C receptors or signaling via
al., 2004), and we cannot eliminate the possibility that melanocortin 4 receptors (Ay) or NPY are equally hypo-
remaining DA receptors may mediate AMPH-induced phagic in response to AMPH, suggesting that these
hypophagia. However, the present results contradict the monoamine and neuropeptide feeding effectors are not
prevailing explanation for hypophagia in response to necessary for hypophagia in response to a moderate
systemic AMPH by demonstrating that activation of D1-, systemic dose of AMPH. Given these results and our
D2-, and - (or any other) adrenergic receptors are not prior observations that NE, Epi, D1-, and D2-receptors are
required for AMPH-induced hypophagia. likewise not required for AMPH-induced hypophagia, we
hypothesized that the effects of AMPH on feeding do
not depend upon monoamines acting primarily at hypo-5-HT2C Receptors, Melanocortin Receptor
thalmic sites associated with the control of feeding. ToSignaling, and NPY Are Not Required
test this hypothesis, we used mice that completely lackfor AMPH-Induced Hypophagia
DA and mice that lack DA in all areas (including theObese mice with impaired 5-HT2C or MC4R receptor
hypothalamus) outside the nigrostriatal terminal fieldssignaling (Htr2c/Y and Ay, respectively) are insensitive
of the caudate-putamen (CPu).to the anorectic effects of serotonin reuptake inhibitors
(Heisler et al., 2003; Heisler et al., 2002; Vickers et al.,
1999), and pharmacological studies have implicated a DA Is Necessary and Striatal DA Dysregulation
Is Sufficient for AMPH-Induced Hypophagiarole for serotonin in AMPH-induced hypophagia (Parada
et al., 1988a, 1992). Because activation of several differ- DA is required for life-sustaining feeding behavior, as
evidenced by the profound hypophagia of DD mice,ent serotonin receptors may suppress food intake, we
also tested AMPH-induced hypophagia in mice deficient which starve unless maintained by daily injection of the
precursor L-dopa (Zhou and Palmiter, 1995). However,in melanocortin 4 receptor (MC4R) activation, because
signaling via MC4R may be necessary for serotonin’s DD mice do manifest some ingestive behavior in the
absence of releasable DA (Cannon and Palmiter, 2003).effects on food intake. For example, mice that express
the MC4R antagonist agouti ectopically (Ay) are hyper- We observed their response to AMPH using computer-
ized lickometer cages, which record each individual lickphagic, obese, and (like 5-HT2C and 5-HT1B knockout
mice) insensitive to the anorectic effects of serotonin (Figure 6). To obtain similar levels of intake in the DD
mice and controls in response to PBS, the mice werereuptake inhibitors such as d-fenfluramine and m-chlo-
rophenylpiperazine (Butler and Cone, 2002 ; Heisler et not fasted, and basal licking (Figure 7A) and activity
(Figure 7D) in the 2 hr preceding injection were lowal., 2003; Heisler et al., 2002; Tecott and Abdallah, 2003;
Vickers et al., 1999). Thus, Htr2c/Y and Ay mice might for both genotypes. Both DD and control mice initiated
intake in response to injection with PBS (Figure 7B),be expected to demonstrate comparable insensitivity to
AMPH, if AMPH-induced hypophagia is mediated via presumably due to the mild stress of being handled
and injected. In response to AMPH 24 hr after L-dopa,this hypothalamic circuit. However, both Htr2c/Y and Ay
mice demonstrated equivalent AMPH-induced hypo- control mice reduced intake, but DD mice did not (Figure
7B). This is consistent with the response of reserpinizedphagia (Figures 5A and 5C) and hyperactivity (Figures
5B and 5D). The obese Ay mice (27.2  1.1 g) were not rats to AMPH, in which a single injection of AMPH stimu-
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lated feeding (Neill and Grossman, 1971). In fact, DD
mice given AMPH drank more than when given PBS
(p  0.01).
Some residual DA remains 24 hr after L-dopa, and
this DA is liberated by AMPH, which accounts for the
locomotor activation of DD mice following the first dose
of AMPH (Figure 7E). However, after purging the residual
DA by prior AMPH treatment, DD mice demonstrated no
locomotor activation in response to subsequent AMPH
(Figure 7F), in agreement with previous results (Cannon
and Palmiter, 2003; Heusner et al., 2003; Szczypka et
al., 1999). DD mice responded to the second injection
of AMPH with increased feeding (Figure 7C). Thus, injec-
tion of AMPH failed to suppress the intake of liquid diet
by DD mice in the absence of any releasable DA or
locomotor hyperactivity.
Restoration of DA to the dorsal striatum (caudate pu-
tamen [CPu]) using recombinant adeno-associated vi-
ruses expressing tyrosine hydroxylase (TH) and GTP
cyclohydrolase 1 (GTPCH1) rescues feeding behavior in
DD mice, such that they can sustain themselves without
L-dopa injections (Szczypka et al., 2001). In the present
study, virally rescued DD mice (vrDD) respond to a fast
with increased food intake (Figure 7G). In response to
AMPH, vrDD mice reduced food intake similar to control
mice (Figure 7G). Thus, AMPH-induced hypophagia is
intact in the complete absence of hypothalamic DA.
Taken together with our prior results, that NE and Epi
are not required, we conclude that hypothalamic cate-
cholamines are not necessary for hypophagia in re-
sponse to a moderate systemic dose of AMPH. The
vrDD mice were more active during the basal, fasting
interval relative to controls; however, vrDD mice actually
decreased their locomotor behavior once food was pre-
sented (Figure 7H). The locomotor response of vrDD
mice to AMPH was blunted (Figure 7H) because DA
action in the NAc is required for hyperactivity after AMPH
(Heusner et al., 2003; Kelly et al., 1975). However, the
vrDD mice did manifest some behavioral signs of AMPH
treatment not observed after injection with PBS, includ-
ing sniffing and occasional sprints down the length of
the cage. They were not in stereotypy.
In conclusion, mice lacking DA are resistant to the
deprivation-induced intake after PBS injection (p  0.01). In this
experiment, the Npy/ mice tended to manifest less robust fasting-
induced hyperphagia in the first 30 min after PBS, although this
trend was not significant.
Figure 5. Ay, Htr2c/Y, and Npy/ Mice Demonstrate Robust AMPH- (F) Npy/ and Npy/ mice maintained on the 129/SvCPJ back-
Induced Hypophagia ground demonstrated significant hyperactivity after injection with
(A) Naive 3- to 5-month-old male mice (7 Htr2c/Y and 8 Htr2c/Y) AMPH (2 g/g) (p  0.05), although their response at this dose
reduced fasting-induced intake in response to AMPH (p  0.01). was not as robust as that of mice maintained on the C57BL/6J or
(B) Hyperactivity in response to AMPH was observed in both Htr2c/Y mixed backgrounds.
and Htr2c/Y mice (p 0.01). Htr2c/Y and Htr2c/Y mice were tested (G) Naive 4-month-old male mice (6 Npy/ and 7 Npy/) were
in a separate animal facility using the same protocol. significantly hypophagic in response to AMPH (4g/g) as compared
(C) Naive 2-month-old female mice (6 C57BL/6J controls and 6 Ay) to deprivation-induced intake after PBS injection (p  0.01).
responded with robust hypophagia after systemic AMPH (p 0.01), (H) Npy/ and Npy/ mice demonstrated significant hyperactivity
although the hyperphagic response to fasting of Ay mice was less after injection with AMPH (4 g/g) (p  0.05), although the ambula-
than that of controls (p  0.01). tory response of the Npy/ mice was limited as they quickly entered
(D) Both control and Ay mice demonstrated comparable hyperactiv- a stereotypic behavioral pattern. Increased anxiety may have con-
ity in response to AMPH (p  0.01), although the Ay mice were less tributed to their reduced hyperlocomotion (a movie documenting
active prior to injection (p  0.05). the behavioral responses of Npy/ and Npy/ mice to AMPH is
(E) Naive 3-month-old male mice (7 Npy/ and 8 Npy/) were signifi- included with the Supplemental Data [http://www.neuron.org/cgi/
cantly hypophagic in response to AMPH (2 g/g) as compared to content/full/44/3/509/DC1/]).
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Figure 6. Procedure for Tests of AMPH-
Induced Hypophagia in DD Mice
(A) L-dopa was given daily, except on the day
of testing. Twenty-four hours after L-dopa in-
jection, an initial dose of AMPH (2 g/g) was
administered to eliminate any residual DA in
dopaminergic terminals from prior L-dopa
treatment. Two hours later, a second dose
of AMPH was administered to determine the
response of DD mice to AMPH in the absence
of releasable DA.
(B) Because DD mice are profoundly hypo-
phagic and may, in addition, have difficulty in grasping and manipulating solid food pellets, we tested these mice for their response to AMPH
in computerized lickometer chambers that were modified for mice as described (Cannon and Palmiter, 2003). Mice lived in the chambers
during the duration of the experiment, and were given access to the palatable liquid diet LD-101 and water at all times.
hypophagic effects of AMPH and will, in fact, increase Morley et al., 1982; Samarghandian et al., 2003), and
electrical brain stimulation (Phillips and Nikaido, 1975).food intake after AMPH injection. Restoration of DA sig-
Animals lacking striatal DA remain sensitive to homeo-naling to only the CPu restored the hypophagic re-
static drives such as hunger (Papp and Bal, 1987) andsponse to AMPH. These data support the hypothesis
demonstrate intact responses to natural rewards suchthat AMPH-induced hypophagia can be caused by re-
as sucrose (Cannon and Bseikri, 2004; Cannon and Pal-lease of DA only in the striatum and are able to explain
miter, 2003) but are not capable of adequate feeding be-observations that were inconsistent with previous ac-
havior.counts of AMPH-induced hypophagia. For example, it
Separate and fundamentally different controls of feed-has been suggested that hypothalamic catecholamine
ing are exerted by catecholamines in different brain ar-receptors were not required, because excitotoxic le-
eas (Hanlon et al., 2003; Hoebel et al., 1989; Kaplan andsions of the LH did not attenuate AMPH-induced hypo-
Sodersten, 1994; Sederholm et al., 2002). That striatalphagia (Clark et al., 1992; Winn et al., 1984). Our results
DA is “downstream” of hypothalamic DA is consistentalso agree with the observation that AMPH does not
with the ability of D2 and -adrenergic antagonists givenreduce the voluntary intake of a diet infused directly into
locally into the pfLH to attenuate the hypophagic effectsthe mouth, but does reduce the intake of the same diet
of low doses (0.5–1 g/g) (Leibowitz, 1975a) but notwhen available from a bottle in the cage (Wolgin et al.,
moderate or high doses of AMPH (Gilbert and Cooper,1988), suggesting that AMPH reduces food intake with-
1985; Sanghvi et al., 1975). DA, NE, and Epi are releasedout necessarily reducing hunger.
in the pfLH during feeding (Yang and Meguid, 1995; Yang
et al., 1996) and suppress feeding at D2 and-adrenergicGeneral Discussion
receptors, respectively (Yang et al., 1997), while D2 andWe suggest that the effects of DA in the CPu on feeding
-adrenergic receptor antagonists stimulate feeding in
are “downstream” of identified pathways controlling
the pfLH (Leibowitz and Rossakis, 1979; Parada et al.,
food intake in other brain areas, including the hypothala-
1988b). Thus, after a low dose of AMPH that did not
mus, NAc, cortex, and brainstem. This is predicated result in excessive striatal DA release, the hyperphagic
upon the number and variety of feeding effectors that effect of DA blockade in the hypothalamus was revealed
fail to affect feeding in the absence of regulated striatal (Leibowitz, 1975a). However, after higher doses of AMPH,
DA signaling. Mice lacking both DA and leptin (DD  blockade of DA receptors in the pfLH could not increase
ob/ob) are as hypophagic as DD mice, despite greater feeding (Gilbert and Cooper, 1985; Sanghvi et al., 1975).
levels of locomotor activity (Szczypka et al., 2000), and We suggest that this is because excessive DA release
weight loss and aphagia are observed following severe in the striatum interfered with feeding behavior.
6-OHDA lesions in all obese models studied (e.g., Bailey In addition to our viral rescue experiments, substantial
and Flatt, 1990; Pelleymounter and Lorden, 1983). Fur- evidence suggests that DA signaling in the CPu is impor-
thermore, insufficient DA or blockade of DA receptors tant for the feeding behavior of normal individuals. The
abolishes the hyperphagic effects of diverse orexigenic CPu receives topographic, glutamatergic projections
stimuli, including NPY (Levine and Morley, 1984), insulin from feeding-associated areas of the cortex where le-
(Breese et al., 1973; Marshall and Teitelbaum, 1973), the sions produce aphagia (Kolb and Nonneman, 1975; Kolb
glucose antimetabolite 2-deoxyglucose (Lu and Row- et al., 1977). Food, and food-related stimuli, such as the
land, 1993), the fatty acid oxidation inhibitor mercap- smell and sight of food, enhance activity in the caudate
toacetate (Garosi et al., 1995), serotonin 1A receptor and putamen in humans (Gautier et al., 1999) and in-
agonists such as 8-OH-DPAT and busprione (Fletcher, crease release of DA in the CPu of animals (Itoh et al.,
1991; Fletcher and Davies, 1990), the benzodiazepine 1990; Joseph and Hodges, 1990). Although excessive
diazepam (Naruse et al., 1991), the cholinergic agonist release of DA causes hypophagia, modest increases in
carbachol (Parker et al., 1991), intraaccumbens block- DA signaling in the CPu can elicit feeding in sated ani-
ade of glutamate receptors (Maldonado-Irizarry et al., mals (Inoue et al., 1997; Pal and Thombre, 1993). In
1995), local injection of muscimol into the nucleus raphe addition, obesity and striatal DA receptor signaling and
dorsalis (Borsini et al., 1983), morphine-conditioned dysfunction have been associated in humans (Chen,
feeding (Kelley et al., 2000), sham feeding (Schneider, 2001; Noble, 2003; Wang et al., 2001). Thus, acute
changes in the regulation of striatal DA signaling affect1989), tail pinch stress (Antelman and Szechtman, 1975;
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feeding behavior in otherwise normal individuals, and
enduring changes may ultimately influence body weight
and obesity.
The Importance of Regulated DA Release
for Feeding
It has been suggested that striatal DA must remain at
an “optimal level” for feeding behavior to occur (Heffner
et al., 1977). Acute systemic administration of all drugs
that prolong normal DA signaling, including AMPH,
methamphetamine (Kraeuchi et al., 1985), cocaine (Balo-
pole et al., 1979; Morley and Flood, 1987; Wellman et
al., 2002), DA reuptake transporter blockers (van der
Hoek and Cooper, 1994), monoamine oxidase inhibitors
(Banchelli et al., 2001; Durcan et al., 1988), and DA recep-
tor agonists (Chen et al., 2001; Cincotta et al., 1997; AI-
Naser and Cooper, 1994; Kuo, 2002; Rahminiwati and
Nishimura, 1999; Scislowski et al., 1999), can also pro-
duce hypophagia. Too little DA is equally disruptive to
normal feeding, as demonstrated by the profound hypo-
phagia of animals that lack DA (Szczypka et al., 1999;
Ungerstedt, 1971; Zhou and Palmiter, 1995; Zigmond
and Stricker, 1972). Injection of the DA precursor L-dopa
is sufficient to restore adequate voluntary food intake
in DD mice, demonstrating that the lack of DA is indeed
the primary cause of their hypophagia (Szczypka et al.,
1999 ; Zhou and Palmiter, 1995). The presence of DA
alone, however, cannot normalize striatal function, par-
ticularly with respect to feeding behavior. For example,
DA-releasing grafts of nigral tissue implanted into the
striatum did not reverse the aphagia of rats after bilateral
nigrostriatal lesion by 6-OHDA, despite improvement in
their motor behaviors (Bjorklund et al., 1980). In fact,
aphagia was exacerbated by the DA-releasing grafts
and improved by their subsequent removal, perhaps
because graft-derived DA reduced postsynaptic hyper-
sensitivity to DA released from intact terminals. Like-
wise, DA receptor agonists fail to promote sustained
Figure 7. DD Mice Are Resistant to the Hypophagic Effect of AMPH, feeding in DD mice, perhaps because the agonists do
but Viral Restoration of DA to the CPu Restores AMPH-Induced Hy- not mimic the normal dynamics of dopaminergic signal-
pophagia ing (Kim and Palmiter, 2003). These results suggest that
(A) Nonfasted mice (control, or CT, PBS, n  19; CT AMPH, n  20; mere activation of DA receptors, by pharmacological
DD PBS, n  21; DD AMPH, n  19) demonstrated minimal licking
agonists or DA itself, is inadequate for normal striatalbehavior prior to handling, although CT mice demonstrated more
function with respect to feeding behavior and that thelicking late in the baseline period, F(1,75)  27.6, p  0.01, perhaps
dynamics of dopaminergic signaling may be critical.in response to the entry of the experimenter into the testing room.
(B) Injection (T 2) of AMPH inhibited PBS-injection-induced licking Midbrain dopaminergic neurons become activated by
behavior in CT but not DD mice, such that there was a significant a variety of salient environmental stimuli via neural in-
interaction between dose and genotype F(1,75)  18.8, p  0.01. puts from the amygdala, lateral hypothalamus, accum-
The intake of DD mice following AMPH was greater than that follow-
bens, pedunculopontine nucleus, and feedback froming PBS (p  0.01)
the striatum and pars reticulata, resulting in bursts of(C) After a second injection (T  4), there was a significant effect
action potentials and increased release of DA in theof genotype, F(1,75)  9.5, p  0.01. The consumption by CT mice
following AMPH was significantly suppressed as compared to the striatum. Bursts of impulses result in much higher tran-
intake of DD mice after AMPH, p  0.01.
(D) Basal activity of nonfasted male and female CT (n  6) and DD
(n  8) mice was low prior to handling.
(E) The first injection of AMPH (T  2) 24 hr after L-dopa stimulated (H) Activity of vrDD mice during the baseline period was significantly
locomotion in CT and DD mice. greater than that of the CT mice (p  0.01). Female and male vrDD
(F) A second injection of AMPH (T  4) stimulated locomotion in CT mice were not significantly more or less hyperactive after AMPH as
but not DD mice. The effect of PBS on CT and DD mice in this compared to their fasted, baseline activity, although there was a
protocol has been published previously (Heusner et al., 2003). trend toward less activity in the 2 hr following AMPH (p  0.07).
(G) Male and female mice (7 vrDD and 6 CT) were significantly Fasting may have resulted in the basal hyperactivity of the vrDD
hypophagic in response to AMPH (2 g/g) as compared to depriva- mice, as consumption of food following PBS injection reduced their
tion-induced intake after PBS injection (p 0.05). For histology of a activity. However, after AMPH, neither group demonstrated stereo-
representative viral injection site, see the Supplemental Data (http:// typy, and unfasted vrDD mice do not respond to AMPH with hyper-
www.neuron.org/cgi/content/full/44/3/509/DC1/). activity (Heusner et al., 2003).
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sient extracellular concentrations of DA than the same ing, perhaps acting directly on other hypothalamic nuclei
number of more evenly spaced impulses (Grace and (Leibowitz, 1970a, 1975b). Though hypothalamic cate-
Bunney, 1984; Nissbrandt et al., 1994). As a conse- cholamines may play a role in the control of feeding, the
quence, D1 receptors, which have a lower affinity for DA present results support the hypothesis that regulated
than D2 receptors, are activated preferentially during striatal dopamine signaling is required for adequate
bursts (Venton et al., 2003). Because mice lacking either feeding. A major hurdle at this stage is to understand
D1 or D2 receptor signaling are able to eat, we suggest where and how the CPu interacts with brainstem, hypo-
that neither receptor is required for regulated signaling thalamic, limbic, cortical, and thalamic pathways to or-
to occur. Rather, the temporal pattern of regulated DA ganize behavioral responses that satisfy hedonic and
release in the striatum may modulate coincident cortical homeostatic drives.
and thalamic inputs and amplify the difference between
strong and weak signals (Nicola et al., 2000). Experimental Procedures
Our working hypothesis is that appropriate striatal
Subjectsintegration of these diverse inputs may be essential for
All experiments were conducted in accordance with the guidelinesthe ability to respond to salient environmental stimuli
of the Institutional Animal Care and Use Committee. All mice wereand homeostatic drives such as hunger and thirst with
bred and housed in a specific pathogen-free facility. Rooms wereappropriate goal-directed behaviors, mediating the
temperature and humidity controlled with a 12:12 light-dark cycle,
translation of homeostatic integration of metabolic and with lights on at 0700 or 0800 hr. Standard polycarbonate home
lipostatic signals into behavior. Striatal DA is not neces- cages contained 1/8 inch BED-O-COB bedding (Animal Specialties)
sary for motor behavior per se but is necessary to direct and a cotton nestlet block (Ancare Corp., N. Belmore, NY). Water
was available ad libitum. Mice congenitally deficient in dopaminemotor behavior toward appropriate goals. For example,
-hydroxylase (Dbh/) were produced as described (Thomas et al.,depletion of DA from the caudate results in profound
1995) and maintained on a mixed 129/SvCPJ and C57BL/6J hybridhypophagia and hypoactivity, while surgical removal of
background. Heterozygous littermates (Dbh/) were used as con-
the entire striatum, which also results in profound and trols for the Dbh/ mice because they have normal levels of norepi-
irreversible hypophagia, is instead accompanied by in- nephrine and epinephrine (Thomas et al., 1998). Neuropeptide Y
tense hyperactivity (Sorenson and Ellison, 1970; Whittier knockout mice and controls (Npy/ and Npy/) (Erickson et al.,
1996) were maintained on a 129/SvCPJ background. Mice congeni-and Orr, 1962). It is clear that excessive and/or unregu-
tally deficient in dopamine D2 receptors (D2r/) (Kelly et al., 1997)lated striatal DA does not disrupt locomotion, because
or D1 receptors (D1r/) (Drago et al., 1994) were maintained on aAMPH, cocaine, and other dopaminergic drugs cause
C57BL/6J background. Heterozygous male and female mice werehyperactivity. And while manipulation of the CPu affects
bred to generate homozygous knockout and wild-type progeny.
other goal-oriented tasks in addition to feeding behav- Mice were genotyped by PCR. Agouti obese (Ay) mice and age-
ior, regulated release of striatal DA may not be similarly matched C57BL/6J controls were obtained from Jackson Labs (Bar
required for all goal-oriented behaviors. The consump- Harbor, ME). Male hemizygous (the Htr2c gene is X-linked [Milato-
vich et al., 1992]) 5-HT2C receptor mutant (Htr2c/Y) and wild-typetion of freely available foods, operant responding for
mice (Htr2c/Y) were bred as described on a congenic C57BL/6Jfood reward, and intracranial self-stimulation all depend
background (Nonogaki et al., 1998). Mice lacking tyrosine hydroxy-upon DA in the CPu (Baunez et al., 1995; Bittner et al.,
lase (TH) in dopaminergic neurons (DD or Th/; DbhTh/) were bred
1981; Fray et al., 1983; Inoue et al., 1995; Neill et al., as described and maintained on a mixed C57BL/6  129/SvEv ge-
1975), but self-stimulation and operant responding are netic background (Zhou and Palmiter, 1995). Littermate controls
increased by the same doses of systemic AMPH that (CT) had at least one intact Th and one intact Dbh allele, which are
sufficient for production of nearly normal levels of DA and NE (Riosreduce the consumption of freely available food in fasted
et al., 1999; Thomas et al., 1998). DD mice were injected daily withanimals (Brady, 1956; Phillips et al., 1991; Skinner and
3,4 dihydroxyphenylalanine (L-dopa, 50 g/g IP), a DA precursor.Heron, 1937; Zhang et al., 2003), suggesting that regu-
Mice were maintained on and tested with pelleted higher energylated release of striatal DA is particularly important for
(11% fat) breeder diet (5LJ5, PMI Nutritional Inc., Brentwood, MO);
feeding. The present data, taken together with an exten- the higher energy diet was necessary for some of the knockout
sive literature, suggest that after moderate doses of strains to maintain weight during repeated fasting.
AMPH, hypophagia is not caused primarily by loss of
appetite but that the hypophagia resulting from either Viral Restoration of DA
too much or too little DA is instead caused by “an altered DA production was restored in the CPu by local injection of two
brain state in which animals cannot respond selectively” recombinant adeno-associated viruses (pAAV-1) expressing tyro-
(Heffner et al., 1977), particularly to internal homeostatic sine hydroxylase (pAAV2-CBA-rTH-CMV-DsRed2, at a titer of 3.6 
1012 genomic particles/ml) and GTP cyclohydrolase 1 (1-pseu-and motivational drives.
dotyped AAV2-CBA-hGTPCH1-CMV-DsRed2, 5 1012). We injectedIn conclusion, our current conception of the role of
0.8 l of these viruses combined in a 1:1 mixture bilaterally into thestriatal DA in feeding suggests that the output of the
dorsal striatum (caudate putamen), using the coordinates 0.8 mm
striatum, which is modulated by regulated DA release, rostral and 2.19 mm lateral to bregma and 3.59 mm beneath the
is essential for adequate feeding behavior. As a conse- skull as described (Heusner et al., 2003; Szczypka et al., 2001).
quence, interference with transient changes in DA sig- Transduced cells produced the precursor L-dopa, which was taken
naling in the striatum, which result from burst firing of up by dopaminergic terminals and converted to DA. Because the
vrDD mice were used in additional experiments subsequent (but notdopaminergic neurons, inhibits voluntary food intake.
prior) to the present studies, placement could not be verified byAMPH-induced release of monoamines, including DA, in
histology in every mouse (although see the Supplemental Data forother brain regions may contribute to the overall effect.
a representative injection site [http://www.neuron.org/cgi/content/
However, this view is fundamentally different than a full/44/3/509/DC1/]). Instead, the “virally rescued” (vrDD) mice were
favored alternative, which suggested that activation identified by their ability to maintain their body weight for more
of hypothalamic dopaminergic nuclei, for example, by than 30 days without L-dopa treatment and respond to a fast with
increased food intake.AMPH-induced release of catecholamines, inhibits feed-
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Drugs of glucose homeostasis in obese hyperglycaemic (ob/ob) mice. Dia-
betes Res. 14, 87–91.All drugs were administered in a volume of 10 l/g body weight
by intraperitoneal (IP) injection using a 30 gauge needle. AMPH Balopole, D.C., Hansult, C.D., and Dorph, D. (1979). Effect of cocaine
(d-Amphetamine sulfate, Sigma Chemical Co., St. Louis, MO) and on food intake in rats. Psychopharmacology (Berl.) 64, 121–122.
the 1/2-adrenergic and 5-HT1/5-HT2 receptor blocker ()-propran- Banchelli, G., Ghelardini, C., Raimondi, L., Galeotti, N., and Pirisino,
olol HCl (RBI, Natick, MA) were dissolved in sterile 10 mM sodium R. (2001). Selective inhibition of amine oxidases differently potenti-
phosphate, 150 mM NaCl, pH 7.5 (PBS). The DA receptor antagonist ate the hypophagic effect of benzylamine in mice. Eur. J. Pharmacol.
haloperidol (Sigma) was dissolved in a minimal volume of 10 N HCl 413, 91–99.
and then diluted with PBS and neutralized to pH 7 with NaOH.
Baptista, T., Teneud, L., and Hernandez, L. (1993). Enhancement of
amphetamine anorexia after chronic administration of sulpiride in
Tests of Amphetamine-Induced Hypophagia rats. Pharmacol. Biochem. Behav. 45, 45–49.
All mice were drug naive and tested as described in Figure 1A,
Baunez, C., Nieoullon, A., and Amalric, M. (1995). Dopamine andwith the exception of the DD and vrDD mice as described below.
complex sensorimotor integration: further studies in a conditionedAmbulations were measured in polycarbonate cages (20  20  40
motor task in the rat. Neuroscience 65, 375–384.cm) equipped with four infrared photobeams, spaced at 8.8 cm
Bittner, S.E., Wagner, G.C., Aigner, T.G., and Seiden, L.S. (1981).apart along the long axis (San Diego Instruments, San Diego, CA),
Effects of a high-dose treatment of methamphetamine on caudateand a water spout inserted 3 cm above the cage floor, in the center
dopamine and anorexia in rats. Pharmacol. Biochem. Behav. 14,of one of the short walls. Each chamber had 1–2 cups of 1/8 inch
481–486.cobb bedding placed roughly in the center. Because DD mice are
profoundly hypophagic and may, in addition, have difficulty in grasp- Bjorklund, A., Dunnett, S.B., Stenevi, U., Lewis, M.E., and Iversen,
ing and manipulating solid food pellets, we tested these mice for S.D. (1980). Reinnervation of the denervated striatum by substantia
their response to AMPH in computerized lickometer chambers (Co- nigra transplants: functional consequences as revealed by pharma-
lumbus Instruments, Columbus, OH) that were modified for mice as cological and sensorimotor testing. Brain Res. 199, 307–333.
described (Cannon and Palmiter, 2003). Mice lived in the chambers Blundell, J.E., and Rogers, P.J. (1980). Effects of anorexic drugs on
during the duration of the experiment and were given access to a food intake, food selection and preference and hunger motivation
palatable liquid diet (LD-101; Test Diet, Richmond, IN) and water at and subjective experiences: Drugs as tools for the investigation of
all times. L-dopa was given daily, except on the day of testing. human feeding. Appetite 1, 151–165.
Twenty-four hours after the prior L-dopa injection, an initial dose of
Booth, D.A. (1968). Amphetamine anorexia by direct action on theAMPH (2 g/g) was administered to eliminate any residual DA in
adrenergic feeding system of rat hypothalamus. Nature 217,dopaminergic terminals from prior L-dopa treatment. Two hours
869–870.later, a second dose of AMPH was administered to determine the
Borsini, F., Bendotti, C., Przewlocka, B., and Samanin, R. (1983).response of DD mice to AMPH in the absence of releasable DA.
Monoamine involvement in the overeating caused by muscimol in-Virally injected (vrDD) mice and controls were tested for AMPH-
jection in the rat nucleus raphe dorsalis and the effects of d-fenflura-induced hypophagia under the standard protocol (Figure 1A), with
mine and d-amphetamine. Eur. J. Pharmacol. 94, 109–115.the following exceptions. Mice were tested twice, in counterbal-
anced order for AMPH or PBS. The vrDD and control mice were Brady, J. (1956). Assessment of drug effects on emotional behavior.
allowed access to food and water ad libitum for 5–7 days before Science 123, 1033–1034.
the protocol was repeated with the treatments reversed. Some of Breese, G.R., Smith, R.D., Cooper, B.R., and Grant, L.D. (1973).
the rescued mice lost weight and stopped eating after AMPH. These Alterations in consummatory behavior following intracisternal injec-
mice were given a single dose of L-dopa 48 hr after AMPH, which tion of 6-hydroxydopamine. Pharmacol. Biochem. Behav. 1,
reversed the aphagia. 319–328.
Butler, A.A., and Cone, R.D. (2002). The melanocortin receptors:
Statistics lessons from knockout models. Neuropeptides 36, 77–84.
Data were analyzed by repeated measures ANOVA, followed by
Cannon, C.M., and Bseikri, M.R. (2004). Is dopamine required for
Tukey’s post hoc analyses with the program STATISTICA 6.0 (Stat-
natural reward? Physiol. Behav. 81, 741–748.
Soft, Tulsa, OK). Where results refer to an ANOVA analysis for either
Cannon, C.M., and Palmiter, R.D. (2003). Reward without dopamine.main effect or the effect of genotype, the F value is given. In all
J. Neurosci. 23, 10827–10831.other instances, the p value refers to the Tukey’s comparison.
Chen, J. (2001). Dopamine D2 receptor and obesity. Lancet 357,
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